Stock BMRN BIOMARIN PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-07 EDT 		5-day change 1st Jan Change
82.58 USD +0.58% Intraday chart for BioMarin Pharmaceutical Inc. +2.25% -14.35%
05-06 Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing MT
05-04 Biomarin Pharmaceutical Inc. Announces Positive New Data Supporting the Safety and Efficacy of VOXZOGO® in Children CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing
MT
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer
MT
Biomarin Announces Board Changes, Effective May 20, 2024
CI
Biomarin Pharmaceutical Inc. Announces Resignation of Jeffrey Ajer as Executive Vice President and Chief Commercial Officer, Effective from July 1, 2024
CI
Biomarin Pharmaceutical Insider Sold Shares Worth $1,945,700, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $939,900, According to a Recent SEC Filing
MT
BioMarin Pharmaceutical Inc. Announces Board Appointments, Effective December 27, 2023
CI
Biomarin Pharmaceutical Insider Sold Shares Worth $1,311,709, According to a Recent SEC Filing
MT
Activist investor Elliott targets drugmaker BioMarin -sources
RE
Biomarin Pharmaceutical Inc. Announces CEO Changes
CI
Biomarin Pharmaceutical Inc. Announces Executive Changes
CI
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. News BioMarin Pharmaceutical Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW